BRCA1 and ovarian carcinoma: Participants were initially reluctant to test, claiming “low risk” (or no risk), a “hazy” perception of hereditary transmission and the gendering of breast cancer.21 No reference was made regarding the risk of ovarian cancer associated with the BRCA1/2 genes.